Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Assistance Publique Hopitaux De Paris
Sponsor

Assistance Publique Hopitaux De Paris

France Porte 23, 1 Avenue Claude Vellefaux, 75475 Paris, France

About the sponsor

Clinical research includes acute leukemias, multiple myeloma, myelodysplastic syndrome, myelofibrosis, primary CNS lymphoma, and other hematologic malignancies, with strong activity in stem cell transplantation and transplant-related complications.

  • Acute lymphoblastic leukemia
  • Acute myeloid leukemia
  • Multiple myeloma
  • Allogeneic hematopoietic stem cell transplantation
  • Graft-versus-host disease

Research also covers lymphoma, plasma cell leukemia, and post-transplant immune complications in adult and pediatric populations.

About Specializations

Assistance Publique Hopitaux De Paris runs clinical trials in conditions such as Haemophagocytic lymphohistiocytosis, Sickle cell disease, Sepsis, Hepatocellular carcinoma, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

251 clinical trials

A study evaluating the efficacy and safety of secukinumab compared to a drug combination in patients with severe Takayasu arteritis.

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:Assistance Publique Hopitaux De Paris

Arthritis infective

Recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Prednisone
  • Sponsor:Assistance Publique Hopitaux De Paris

Sickle cell disease

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years
  • Substances:Imatinib
  • Sponsor:Assistance Publique Hopitaux De Paris

Sepsis

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Anakinra
  • Sponsor:Assistance Publique Hopitaux De Paris

Cutaneous lupus erythematosus

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Lenalidomide
  • Sponsor:Assistance Publique Hopitaux De Paris

Renal cell carcinoma

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:RUBIDIUM CHLORIDE
  • Sponsor:Assistance Publique Hopitaux De Paris

Pulmonary tuberculosis

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bedaquiline
  • Sponsor:Assistance Publique Hopitaux De Paris

Pulmonary arterial hypertension

Recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ambrisentan
  • Sponsor:Assistance Publique Hopitaux De Paris

Cryoglobulinaemia

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Obinutuzumab
  • Sponsor:Assistance Publique Hopitaux De Paris

Poisoning

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Charcoal, Activated
  • Sponsor:Assistance Publique Hopitaux De Paris

Inflammatory bowel disease

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · Healthy volunteers
  • Substances:Amphotericin B
  • Sponsor:Assistance Publique Hopitaux De Paris

Toxic epidermal necrolysis

Recruiting
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Allogeneic Adipose-Derived Mesenchymal Stromal Cells, Ex-Vivo Expanded
  • Sponsor:Assistance Publique Hopitaux De Paris

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

ClinicalTrials.eu

Every clinical trial in Europe, in plain language.

Explore the full ecosystem of clinical research in Europe.

Search trials

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).